About Urethral Bulking Systems
Involuntary loss of urine during a period of elevated abdominal pressure and in the absence of detrusor activity is known as stress urinary incontinence (SUI). Bulking drugs administered in the urethra are a relatively new but well-established therapeutic option for SUI. Understanding the demographics of SUI can aid in the selection of patients who will benefit from bulking agent therapy. In women, urethral thickening is normally performed under local anaesthetic, whereas men may require general or regional anaesthesia. After an injection, a local anaesthetic lets the person to get up to see if continence has been attained.
|Unit||Value (USD Million)|
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Urethral Bulking Systems market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
CR Bard (Becton, Dickinson and Company.) (United States), Merz Pharma GmbH & Co. KGaA (Germany), Cogentix Medical (Laborie, Inc.) (United States), Q-Med (Sweden), Ascentx Medical, Inc. (United States), Coloplast Corp (United States), Boston Scientific Corporation (United States) and AstraZeneca plc (United Kingdom) are some of the key players that are part of study coverage.
AMA Research has segmented the market of Global Urethral Bulking Systems market by and Region.
On the basis of geography, the market of Urethral Bulking Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Endoscopic will boost the Urethral Bulking Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Indication, the sub-segment i.e. Stress Urinary Incontinence will boost the Urethral Bulking Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Use, the sub-segment i.e. Hospitals will boost the Urethral Bulking Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On 28th January, 2020 - Contura International A/S Received US FDA Approval for its Application for Bulkamid Urethral Bulking System - P170023. Bulkamid is a Thick, Lasting Gel Is Used for Treatment of Stress Urine Incontinence in Women Who Have Weak Pelvic Floor Muscles (Urethral Sphincter).
- Prevalence of Stress Urinary Incontinence (SUI)
- Growing Healthcare Awareness
- High Investment in Healthcare R&D
- Growing Medical Infrastructure Across Emerging Regions
- Fierce Competitive Pressure
Key Target AudienceUrethral Bulking Systems Manufactures, New Entrants and Investors, Urethral Bulking Systems Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
About ApproachTo evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.